Fighting the spread of AmpC-hyperproducing enterobacteriaceae: Beneficial effect of replacing ceftriaxone with cefotaxime

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 786-789

  Grohs, P ^a   Kerneis S ^a,b,c   Sabatier, B ^a,d   Lavollay, M ^a,b   Carbonnelle, E ^a,b   Rostane, H ^a   Souty, C ^c   Meyer, G ^a,b,d   Gutmann, L ^a,b   Mainardi, J L ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antibiotics; Bacterial resistance; Cephalosporins

Indexed keywords

AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE;

DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RETROSPECTIVE STUDY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFOTAXIME; CEFTRIAXONE; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INCIDENCE; RETROSPECTIVE STUDIES;

EID: 84894043896     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt403     Document Type: Article

References (16)

1. Pitout JD, Laupland KB. Extended-spectrum b-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
2. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type b-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
3. De Kraker ME, Wolkewitz M, Davey PG et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011; 66: 398-407.
4. Donskey CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant Gram-negative bacilli. Clin Infect Dis 2006; 43 Suppl 2: S62-9.
5. Meyer E, Lapatschek M, Bechtold A et al. Impact of restriction of third-generation cephalosporins on the burden of third-generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med 2009; 35: 862-70.
6. Owens RC Jr, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis 2006; 42 Suppl 4: S173-81.
7. Vignoli R, Calvelo E, Cordeiro NF et al. Association of broad-spectrum antibiotic use with faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae in an intensive care unit. J Hosp Infect 2006; 63: 306-15.
8. Muller A, Lopez-Lozano JM, Bertrand X et al. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J Antimicrob Chemother 2004; 54: 173-77.
9. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2013. http://www.whocc.no/filearchive/ publications/1_2013guidelines.pdf (29 May 2013, date last accessed).
10. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of antimicrobial susceptibility test breakpoints. Clin Microbiol Infect 2000; 6: 570-2.
11. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
12. Morgan OW, Griffiths C, Majeed A. Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PLoS Med 2007; 4: e105.
13. R Development Core Team. R Foundation for Statistical Computing, Vienna,Austria. http://www.R-project.org (14 June2013, date last accessed). 14 Weber DA, Sanders CC. Diverse potential of b-lactamase inhibitors to induce class I enzymes. Antimicrob Agents Chemother 1990; 34: 156-8.
14. Weber DA, Sanders CC. Diverse potential of b-lactamase inhibitors to induce class I enzymes. Antimicrob Agents Chemother 1990; 34: 156-8.
15. Courpon-Claudinon A, Lefort A, Panhard X et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011; 17: 557-65.
16. Thiébaut AC, Arlet G, Andremont A et al. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother 2012; 67: 1525-36.